Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Goeree

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|July 27, 2007
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major traumaLarry D Lynd, Ron Goeree, Mark A Crowther, et al.
Nephron. Clinical Practice|June 29, 2007
Costs associated with erythropoiesis-stimulating agent administration to hemodialysis patientsDavid N Churchill, David Macarios, Cheryl Attard, et al.
International Journal of Circumpolar Health|September 20, 2011
Health economic evaluations help inform payers of the best use of scarce health care resourcesDaria O'Reilly, Kathryn Gaebel, Feng Xie, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 14, 2007
Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysisDan Comay, Gord Blackhouse, Ron Goeree, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 7, 2014
Utility values for pre-menopausal women suffering from symptomatic uterine fibroidsMarg Hux, Carita Ng, Greta Lozano Ortega, et al.
Ontario Health Technology Assessment Series|October 18, 2012
Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgeryJames M Bowen, O Carter Snead, Kiran Chandra, et al.
Pharmacoeconomics|February 1, 2006
Economic evaluation of rivastigmine in patients with Parkinson's disease dementiaAndrew R Willan, Ron Goeree, Eleanor M Pullenayegum, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 28, 2013
Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiencesBernice Tsoi, Lisa Masucci, Kaitryn Campbell, et al.
Journal of Medical Economics|October 23, 2018
Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspectiveRon Goeree, Sima Chiva-Razavi, Praveen Gunda, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 29, 2003
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux diseasePierre Paré, François Meyer, David Armstrong, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|July 27, 2007
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major traumaLarry D Lynd, Ron Goeree, Mark A Crowther, et al.
Nephron. Clinical Practice|June 29, 2007
Costs associated with erythropoiesis-stimulating agent administration to hemodialysis patientsDavid N Churchill, David Macarios, Cheryl Attard, et al.
International Journal of Circumpolar Health|September 20, 2011
Health economic evaluations help inform payers of the best use of scarce health care resourcesDaria O'Reilly, Kathryn Gaebel, Feng Xie, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|April 14, 2007
Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysisDan Comay, Gord Blackhouse, Ron Goeree, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 7, 2014
Utility values for pre-menopausal women suffering from symptomatic uterine fibroidsMarg Hux, Carita Ng, Greta Lozano Ortega, et al.
Ontario Health Technology Assessment Series|October 18, 2012
Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgeryJames M Bowen, O Carter Snead, Kiran Chandra, et al.
Pharmacoeconomics|February 1, 2006
Economic evaluation of rivastigmine in patients with Parkinson's disease dementiaAndrew R Willan, Ron Goeree, Eleanor M Pullenayegum, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 28, 2013
Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiencesBernice Tsoi, Lisa Masucci, Kaitryn Campbell, et al.
Journal of Medical Economics|October 23, 2018
Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspectiveRon Goeree, Sima Chiva-Razavi, Praveen Gunda, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 29, 2003
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux diseasePierre Paré, François Meyer, David Armstrong, et al.
Pageof 19